![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 2Aurobindo Pharma Limited
02 1Cipla Ltd.
03 2Hetero Labs Limited
04 1Jiangsu Weiqida Pharmaceutical Co., Ltd.
05 1MYLAN LABORATORIES LIMITED
06 1Mylan Laboratories Limited
07 1Tianish Laboratories Private Limited
08 1Vijayasri Organics Private Limited
09 1YiChang HEC ChangJiang Pharmaceuical Co.,Ltd.
Reset all filters
01 4ZIDOVUDINE
02 7Zidovudine
Reset all filters
01 1China
02 7India
03 2U.S.A
04 1Blank
NDC Package Code : 65862-258
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-321
Start Marketing Date : 2024-01-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7545
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (30kg/30kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49587-101
Start Marketing Date : 2011-01-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0017
Start Marketing Date : 1987-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0047
Start Marketing Date : 1987-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-703
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-765
Start Marketing Date : 2017-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70159-003
Start Marketing Date : 2016-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 58326-2172
Start Marketing Date : 2021-06-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Zidovudine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zidovudine, including repackagers and relabelers. The FDA regulates Zidovudine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zidovudine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zidovudine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zidovudine supplier is an individual or a company that provides Zidovudine active pharmaceutical ingredient (API) or Zidovudine finished formulations upon request. The Zidovudine suppliers may include Zidovudine API manufacturers, exporters, distributors and traders.
click here to find a list of Zidovudine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zidovudine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zidovudine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zidovudine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zidovudine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zidovudine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zidovudine suppliers with NDC on PharmaCompass.
We have 7 companies offering Zidovudine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?